<p>(<b>A</b>) Spleens of chronically FV-infected mice from the different treatment groups were analyzed for viral loads by infectious center assays 1 day after termination of treatment. Each dot represents an individual mouse. Data were pooled from 4 to 6 independent experiments with similar results. Statistically significant differences are indicated by asterisks (*<0.05; ***<0.0005; analysis of variance [ANOVA] nonparametric, Dunn's multiple comparison test). (<b>B</b>) To study long-term effects of the treatment spleens of mice from the different groups were analyzed for viral loads by infectious center assay at 21 days post treatment (dpt). Each dot represents an individual mouse.</p
<p>Absolute numbers of thymic Treg (CD3<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>)...
<p>A) Weight changes of mice; B) Mortality of mice; C) Virus titers of the mouse lungs and brains: f...
<p>At day 0, mice were i.m. injected with LPS, CFA or with one of the vaccines (TIV<sup>+</sup>, TIV...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>Gating strategy for Tregs <b>(A-C)</b>. B6-FOXP3-DTR mice were injected with 20,000 SFFU i.v. FV ...
<p>CB6F1 mice were prime- and boost-immunized with Ad.pIXgp70 in combination with interleukin-encodi...
<p>Characterization of the Foxp3<sup>+</sup> Treg cell population in spleen (A–C), liver and kidney ...
<p>B6.FOXP3-DTR mice were injected with 20,000 SFFU i.v. and left untreated or injected with 0.5 μg ...
<p>(A) Three representative RIX lines with disease are compared to the chronic line, with T cell sub...
<p>A) Experimental Setup: C57BL/6 mice were infected for 14 days with <i>L</i>. <i>sigmodontis</i> (...
<p>Mice chronically infected with FV were treated with DT (DEREG mice) and/or blocking antibodies ag...
<p>C57BL/6 mice were left naïve or infected with FV or <i>L</i>. <i>sigmodontis</i> or co-infected w...
<p>C57BL/6 mice were infected with LCMV i.p.. At the indicated times p.i. the spleens, ILNs, MesLNs,...
<p>BALB/c mice were infected with 50 pfu of PR8 virus in 50 µl via the TRT route under penthrane ana...
<p>Groups of 5 mice were infected with either ECTV-WT or ECTV-IFN-γbp<sup>Δ</sup> and sacrificed at ...
<p>Absolute numbers of thymic Treg (CD3<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>)...
<p>A) Weight changes of mice; B) Mortality of mice; C) Virus titers of the mouse lungs and brains: f...
<p>At day 0, mice were i.m. injected with LPS, CFA or with one of the vaccines (TIV<sup>+</sup>, TIV...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>Gating strategy for Tregs <b>(A-C)</b>. B6-FOXP3-DTR mice were injected with 20,000 SFFU i.v. FV ...
<p>CB6F1 mice were prime- and boost-immunized with Ad.pIXgp70 in combination with interleukin-encodi...
<p>Characterization of the Foxp3<sup>+</sup> Treg cell population in spleen (A–C), liver and kidney ...
<p>B6.FOXP3-DTR mice were injected with 20,000 SFFU i.v. and left untreated or injected with 0.5 μg ...
<p>(A) Three representative RIX lines with disease are compared to the chronic line, with T cell sub...
<p>A) Experimental Setup: C57BL/6 mice were infected for 14 days with <i>L</i>. <i>sigmodontis</i> (...
<p>Mice chronically infected with FV were treated with DT (DEREG mice) and/or blocking antibodies ag...
<p>C57BL/6 mice were left naïve or infected with FV or <i>L</i>. <i>sigmodontis</i> or co-infected w...
<p>C57BL/6 mice were infected with LCMV i.p.. At the indicated times p.i. the spleens, ILNs, MesLNs,...
<p>BALB/c mice were infected with 50 pfu of PR8 virus in 50 µl via the TRT route under penthrane ana...
<p>Groups of 5 mice were infected with either ECTV-WT or ECTV-IFN-γbp<sup>Δ</sup> and sacrificed at ...
<p>Absolute numbers of thymic Treg (CD3<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup>)...
<p>A) Weight changes of mice; B) Mortality of mice; C) Virus titers of the mouse lungs and brains: f...
<p>At day 0, mice were i.m. injected with LPS, CFA or with one of the vaccines (TIV<sup>+</sup>, TIV...